Teiko Bio

Summary

Teiko Bio is a Salt Lake City clinical laboratory and contract research organization focused on immune measurement for clinical trials. It combines blood-preservation kits, multiparameter flow-cytometry panels, laboratory processing, quality-controlled gating, and software reports intended to make immune-state data usable by drug-development teams.

Impact

Clinical trials can lose information when blood samples degrade, processing varies between sites, or high-dimensional cytometry produces results that are difficult to compare. Teiko is trying to make immune measurement reproducible across sites and long-running trials, which could help sponsors see whether an immunotherapy is affecting the intended cells and identify response-associated populations earlier. The upper bound is better trial decisions and fewer failed or inconclusive studies; the downside is that a proprietary assay-and-analysis stack can add cost without changing outcomes if its measurements are not independently validated or clinically actionable.

Bet: Standardized specimen preservation, cytometry and analysis can make immune state a routine clinical-trial measurement rather than a specialist research exercise.

Utah Context

Teiko says samples can be shipped to its CLIA-compliant laboratory in Salt Lake City, and its public team spans laboratory operations, cytometry, bioinformatics, commercial work and clinical-laboratory oversight. The company adds a clinical-trial measurement layer to Utah's genomics and diagnostics cluster rather than developing a therapeutic itself.

What They Need Now

Teiko maintains a company Ashby board and is recruiting into the technical bridge between laboratory data and clinical-trial delivery. Durable needs include software and bioinformatics engineering for data pipelines, analysis and customer-facing reports, alongside scientists who understand cytometry, immunology, assay validation and regulated clinical-laboratory workflows. Individual listings will change; candidates should use the board for the current mix.

Open Questions

• Which performance claims have been independently replicated across trial sites, instruments and therapeutic areas?
• How many customers use Teiko prospectively in interventional trials rather than for exploratory or retrospective analysis?
• The company site reports operating scale and laboratory status, but those claims remain self-reported until tied to trial records, publications or a laboratory registry.

Evidence

• Teiko official site — product stack, clinical-trial use, laboratory scale and global-trial positioning: https://teiko-labs.com/
• Teiko team — company mission and current laboratory, bioinformatics, scientific and commercial functions: https://teiko-labs.com/our-team
• Teiko FAQ — Salt Lake City laboratory and TokuKit workflow: https://teiko-labs.com/faq
• Teiko careers board — current applicant destination: https://jobs.ashbyhq.com/teiko